Apex Capital Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$12.9M Buy
181,117
+29,823
+20% +$2.02M 0.28% 99
2015
Q4
$11.4M Buy
151,294
+12,631
+9% +$913K 0.25% 96
2015
Q3
$9.01M Sell
138,663
-9,687
-7% -$640K 0.2% 109
2015
Q2
$9.56M Buy
148,350
+8,982
+6% +$606K 0.2% 101
2015
Q1
$9.79M Buy
139,368
+23,327
+20% +$1.54M 0.23% 92
2014
Q4
$7.53M Buy
116,041
+28,046
+32% +$1.73M 0.2% 97
2014
Q3
$4.75M Buy
+87,995
New +$4.78M 0.14% 120

Other funds holding STE

Apex Capital Management's STE Position: Q1 2016 in Review

Apex Capital Management increased its Steris (STE) stake by 20% in Q1 2016, buying an estimated $2.02M and bringing the position to 181,117 shares worth $12.9M. The position accounts for 0.28% of the portfolio, ranked #99.

Apex Capital Management first reported a position in STE in Q3 2014 and has held it in 7 quarters since. 295 funds tracked by Wall St. Rank hold STE as of Q1 2016.

  • Apex Capital Management held 181,117 shares of Steris worth $12.9M as of Q1 2016.
  • Apex Capital Management bought 29,823 Steris shares in Q1 2016, an estimated $2.02M.
  • Steris made up 0.28% of Apex Capital Management's portfolio in Q1 2016, its #99 holding.
  • Apex Capital Management first reported a position in Steris in Q3 2014 and has held it in 7 quarters since.
  • 295 funds tracked by Wall St. Rank held Steris as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.